Correlation Between Cogent Biosciences and Revolution Medicines
Can any of the company-specific risk be diversified away by investing in both Cogent Biosciences and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cogent Biosciences and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cogent Biosciences and Revolution Medicines, you can compare the effects of market volatilities on Cogent Biosciences and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cogent Biosciences with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cogent Biosciences and Revolution Medicines.
Diversification Opportunities for Cogent Biosciences and Revolution Medicines
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cogent and Revolution is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Cogent Biosciences and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Cogent Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cogent Biosciences are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Cogent Biosciences i.e., Cogent Biosciences and Revolution Medicines go up and down completely randomly.
Pair Corralation between Cogent Biosciences and Revolution Medicines
Given the investment horizon of 90 days Cogent Biosciences is expected to under-perform the Revolution Medicines. In addition to that, Cogent Biosciences is 1.48 times more volatile than Revolution Medicines. It trades about -0.39 of its total potential returns per unit of risk. Revolution Medicines is currently generating about -0.09 per unit of volatility. If you would invest 4,092 in Revolution Medicines on November 30, 2024 and sell it today you would lose (184.00) from holding Revolution Medicines or give up 4.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Cogent Biosciences vs. Revolution Medicines
Performance |
Timeline |
Cogent Biosciences |
Revolution Medicines |
Cogent Biosciences and Revolution Medicines Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cogent Biosciences and Revolution Medicines
The main advantage of trading using opposite Cogent Biosciences and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cogent Biosciences position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.Cogent Biosciences vs. Larimar Therapeutics | ||
Cogent Biosciences vs. Kura Oncology | ||
Cogent Biosciences vs. Kiniksa Pharmaceuticals | ||
Cogent Biosciences vs. Ideaya Biosciences |
Revolution Medicines vs. Blueprint Medicines Corp | ||
Revolution Medicines vs. Sana Biotechnology | ||
Revolution Medicines vs. Kymera Therapeutics | ||
Revolution Medicines vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |